Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Boston Angel Club, also referred to on its website as BAC Capital and Boston Health Fund, is an early-stage investment and incubation organization based in the Greater Boston area. The firm focuses on high-tech startups, with stated emphasis on life science technology, biotech, pharmaceutics, healthcare, artificial intelligence, robotics, and related fields. It describes itself as supporting startup growth, cross-border investment, and transnational M&A, particularly for companies connected to the MIT and Harvard ecosystems. Based on the available public information, this is an investor in healthcare and life sciences rather than an operating biotech or pharmaceutical company with its own therapeutic pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BAC Investments.